Research from three pulmonologists is shining light on mechanotransduction and ECM signal processing in ways that could lead to new therapeutic options
Multidisciplinary approach can uncover unsuspected diagnoses
A multidisciplinary approach to a unique transplant case
![18-PUL-4645-Tolle-Hero-Image-650x450pxl[5]](https://assets.clevelandclinic.org/transform/StoryPanel/d0dfe399-8e94-4a38-a720-258396b54c23/18-PUL-4645-Tolle-Hero-Image-650x450pxl5_jpg?w=3840&q=75)
An overview of available treatment modalities
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
When primary care physicians should suspect IPF
An overview of IPF for primary care physicians
Clinical trials necessary to cure devastating disorder
FDA-approved drugs offer hope for devastating lung disease
Cleveland Clinic researchers have found evidence that manipulating the channel activity of TRPV4 may provide a novel therapeutic approach for fibrotic diseases of the lung and other organs.